BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis

RP Tufano, GV Teixeira, J Bishop, KA Carson, M Xing - Medicine, 2012 - journals.lww.com
Clinicians have long sought to characterize biological markers of neoplasia as objective
indicators of tumor presence, pathogenicity, and prognosis. Armed with data that correlate …
被引用次数：377 相关文章

BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: A systematic review and meta-analysis

RP Tufano, GV Teixeira, J Bishop… - Medicine (United …, 2012 - pure.johnshopkins.edu
Clinicians have long sought to characterize biological markers of neoplasia as objective
indicators of tumor presence, pathogenicity, and prognosis. Armed with data that correlate …
[PDF] mcmaster.ca

[PDF][PDF] BRAF Mutation in Papillary Thyroid Cancer and Its Value in Tailoring Initial Treatment

M Xing - Medicine, 2012 - surgery.healthsci.mcmaster.ca
Clinicians have long sought to characterize biological markers of neoplasia as objective
indicators of tumor presence, pathogenicity, and prognosis. Armed with data that correlate …

BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis.

RP Tufano, GV Teixeira, J Bishop, KA Carson, M Xing - Medicine, 2012 - europepmc.org
Clinicians have long sought to characterize biological markers of neoplasia as objective
indicators of tumor presence, pathogenicity, and prognosis. Armed with data that correlate …

BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: A systematic review and meta-analysis

RP Tufano, GV Teixeira… - Medicine …, 2012 - utsouthwestern.elsevierpure.com
Clinicians have long sought to characterize biological markers of neoplasia as objective
indicators of tumor presence, pathogenicity, and prognosis. Armed with data that correlate …

[引用][C] BRAF Mutation in Papillary Thyroid Cancer and Its Value in Tailoring Initial Treatment

RP Tufano, GV Teixeira, J Bishop, KA Carson, M Xing - Medicine, 2012 - cir.nii.ac.jp
BRAF Mutation in Papillary Thyroid Cancer and Its Value in Tailoring Initial Treatment | CiNii
Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 論文・データをさがす 大学 …
[PDF] archive.org

[PDF][PDF] BRAF Mutation in Papillary Thyroid Cancer and Its Value in Tailoring Initial Treatment

M Xing - Medicine, 2012 - scholar.archive.org
Clinicians have long sought to characterize biological markers of neoplasia as objective
indicators of tumor presence, pathogenicity, and prognosis. Armed with data that correlate …

BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis

RP Tufano, GV Teixeira, J Bishop, KA Carson… - …, 2012 - pubmed.ncbi.nlm.nih.gov
Clinicians have long sought to characterize biological markers of neoplasia as objective
indicators of tumor presence, pathogenicity, and prognosis. Armed with data that correlate …